Inhibition of HTLV-III/LAV replication by foscarnet
- PMID: 2415134
- DOI: 10.1016/0006-2952(85)90392-2
Inhibition of HTLV-III/LAV replication by foscarnet
Similar articles
-
Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate.Lancet. 1985 Jun 29;1(8444):1480-2. doi: 10.1016/s0140-6736(85)92255-x. Lancet. 1985. PMID: 2409414
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1982;19(3):387-415. doi: 10.1016/0163-7258(82)90074-2. Pharmacol Ther. 1982. PMID: 6201932 Review. No abstract available.
-
Foscarnet.Lancet. 1985 Sep 21;2(8456):648-9. Lancet. 1985. PMID: 2863637 No abstract available.
-
Synergistic inhibition of human T-cell lymphotropic virus type III replication in vitro by phosphonoformate and recombinant alpha-A interferon.Antimicrob Agents Chemother. 1986 Jul;30(1):189-91. doi: 10.1128/AAC.30.1.189. Antimicrob Agents Chemother. 1986. PMID: 3019235 Free PMC article.
-
Antiviral effects of phosphonoformate (PFA, foscarnet sodium).Pharmacol Ther. 1989;40(2):213-85. doi: 10.1016/0163-7258(89)90097-1. Pharmacol Ther. 1989. PMID: 2543994 Review.
Cited by
-
Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.Antimicrob Agents Chemother. 1989 May;33(5):663-9. doi: 10.1128/AAC.33.5.663. Antimicrob Agents Chemother. 1989. PMID: 2546487 Free PMC article.
-
Restricted replication of simian immunodeficiency virus strain 239 in macrophages is determined by env but is not due to restricted entry.J Virol. 1993 May;67(5):2807-14. doi: 10.1128/JVI.67.5.2807-2814.1993. J Virol. 1993. PMID: 7682627 Free PMC article.
-
Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis.Antimicrob Agents Chemother. 1989 May;33(5):742-5. doi: 10.1128/AAC.33.5.742. Antimicrob Agents Chemother. 1989. PMID: 2546491 Free PMC article.
-
Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptases.Antimicrob Agents Chemother. 1989 Jan;33(1):115-7. doi: 10.1128/AAC.33.1.115. Antimicrob Agents Chemother. 1989. PMID: 2469389 Free PMC article.
-
Structure-activity relationships of fluorinated nucleoside analogs and their synergistic effect in combination with phosphonoformate against human immunodeficiency virus type 1.Antimicrob Agents Chemother. 1989 Dec;33(12):2083-8. doi: 10.1128/AAC.33.12.2083. Antimicrob Agents Chemother. 1989. PMID: 2533474 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources